Andrew Cheng Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew Cheng.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew Cheng. Andrew Cheng is Director in Arbutus Biopharma Corp ($TKMR) and Chief Executive Officer in Akero Therapeutics, Inc. ($AKRO) and President & CEO in Akero Therapeutics, Inc. ($AKRO) and Director in Vera Therapeutics, Inc. ($VERA).
Latest Insider Trading Transactions of Andrew Cheng
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKRO, TKMR, VERA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2021 | VERA | Vera Therapeutics, ... | Cheng Andrew | Director | Option Exercise | C | 0.00 | 17,488 | 0 | 0 | |
| May 18 2021 | VERA | Vera Therapeutics, ... | Cheng Andrew | Director | Buy | C | 0.00 | 17,488 | 0 | 17,488 | 0 to 17.5 K |
| May 17 2021 | VERA | Vera Therapeutics, ... | Cheng Andrew | Director | Option Exercise | A | 11.00 | 9,925 | 109,175 | 9,925 | |
| Jan 11 2021 | AKRO | Akero Therapeutics ... | Cheng Andrew | President & CEO | Option Exercise | M | 0.62 | 20,000 | 12,300 | 258,712 | |
| Jan 11 2021 | AKRO | Akero Therapeutics ... | Cheng Andrew | President & CEO | Gift | G | 0.00 | 3,000 | 0 | 359,989 | 363 K to 360 K (-0.83 %) |
| Jan 11 2021 | AKRO | Akero Therapeutics ... | Cheng Andrew | President & CEO | Buy | M | 0.62 | 20,000 | 12,300 | 362,989 | 343 K to 363 K (+5.83 %) |
| Dec 29 2020 | AKRO | Akero Therapeutics ... | Cheng Andrew | President & CEO | Option Exercise | M | 0.62 | 7,480 | 4,638 | 278,712 | |
| Dec 29 2020 | AKRO | Akero Therapeutics ... | Cheng Andrew | President & CEO | Option Exercise | M | 0.62 | 7,480 | 4,638 | 278,712 | |
| Dec 29 2020 | AKRO | Akero Therapeutics ... | Cheng Andrew | President & CEO | Buy | M | 0.62 | 7,480 | 4,638 | 342,989 | 335.5 K to 343 K (+2.23 %) |
| Dec 29 2020 | AKRO | Akero Therapeutics ... | Cheng Andrew | President & CEO | Buy | M | 0.62 | 7,480 | 4,638 | 342,989 | 335.5 K to 343 K (+2.23 %) |
| Jun 01 2020 | TKMR | Arbutus Biopharma ... | Cheng Andrew | Director | Option Exercise | A | 2.16 | 22,000 | 47,520 | 22,000 | |
| Dec 13 2019 | AKRO | Akero Therapeutics ... | Cheng Andrew | Chief Executive Off ... | Option Exercise | A | 21.09 | 234,000 | 4,935,060 | 234,000 | |
| Dec 13 2019 | AKRO | Akero Therapeutics ... | Cheng Andrew | Chief Executive Off ... | Option Exercise | A | 21.09 | 234,000 | 4,935,060 | 234,000 | |
| Aug 20 2019 | TKMR | Arbutus Biopharma ... | Cheng Andrew | Director | Option Exercise | A | 1.50 | 60,000 | 90,000 | 60,000 |
Page: 1